about
sameAs
Gender differences in genetic risk profiles for cardiovascular diseaseLymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factorGenetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosisThe role of the CD58 locus in multiple sclerosisSomatic STAT3 mutations in large granular lymphocytic leukemiaA mouse model for Finnish variant late infantile neuronal ceroid lipofuscinosis, CLN5, reveals neuropathology associated with early agingSystematic review of genome-wide expression studies in multiple sclerosisMeta-analysis of genome-wide association studies confirms a susceptibility locus for knee osteoarthritis on chromosome 7q22Efficient discovery of single-nucleotide polymorphisms in coding regions of human genes.Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis.Are data from different gene expression microarray platforms comparable?PRKCA and multiple sclerosis: association in two independent populations.mtDNA nt13708A variant increases the risk of multiple sclerosis.High divergence in primate-specific duplicated regions: human and chimpanzee chorionic gonadotropin beta genesAllelic variants of IL1R1 gene associate with severe hand osteoarthritis.Somatic mutations in clonally expanded cytotoxic T lymphocytes in patients with newly diagnosed rheumatoid arthritis.Comparison of solution-based exome capture methods for next generation sequencingAn immune response network associated with blood lipid levels.High-resolution SNP array analysis of patients with developmental disorder and normal array CGH results.Genetic background of extreme violent behavior.Autoimmunity, hypogammaglobulinemia, lymphoproliferation, and mycobacterial disease in patients with activating mutations in STAT3.Complete primary structure of two variant forms of human type XVIII collagen and tissue-specific differences in the expression of the corresponding transcripts.Association analysis of the LAG3 and CD4 genes in multiple sclerosis in two independent populations.Risk alleles of USF1 gene predict cardiovascular disease of women in two prospective studies.Whole genome amplification with Phi29 DNA polymerase to enable genetic or genomic analysis of samples of low DNA yield.Pharmacogenomics of hypertension: a genome‐wide, placebo‐controlled cross‐over study, using four classes of antihypertensive drugs.Inherited DOCK2 Deficiency in Patients with Early-Onset Invasive Infections.Class II HLA interactions modulate genetic risk for multiple sclerosis.Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populationsUse of a genetic isolate to identify rare disease variants: C7 on 5p associated with MS.Genomic association analysis of common variants influencing antihypertensive response to hydrochlorothiazide.MYO9B polymorphisms in multiple sclerosisCrowdsourced assessment of common genetic contribution to predicting anti-TNF treatment response in rheumatoid arthritis.Enrichment of rare variants in population isolates: single AICDA mutation responsible for hyper-IgM syndrome type 2 in FinlandAnalysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis.The Twin Spine Study: contributions to a changing view of disc degeneration.Segmental duplications flank the multiple sclerosis locus on chromosome 17q.Gene expression patterns in a rodent model for depression.Functional variations modulating PRKCA expression and alternative splicing predispose to multiple sclerosis.Damaging heterozygous mutations in NFKB1 lead to diverse immunologic phenotypes.
P50
Q21092169-3E9F5EFF-7236-49B3-A6A4-2F33F59B04E2Q24305315-1E4D99A4-BA41-4566-AF06-4F0DD59E0B72Q24635370-379D6C4D-7C60-49C1-9BFF-73F2C1FC3F14Q24649291-6C34CF75-3C4A-46D8-A0DC-A5D6092C8FC3Q27851792-BFCDACC1-B39E-41B1-B22C-792ACFC94D46Q28593206-2DC5E335-4883-4016-AECA-CF7730DAE9BAQ28744024-2225C118-B723-4DA7-AC7A-95BCC43377F2Q29417079-F0C10A84-91E3-432A-84C2-3AC060767597Q30331603-41F1772B-8941-4798-98E2-A212E2149EA6Q30416155-F29F7065-A013-4C22-8528-E5D3A2D5DF14Q30936542-26E1D509-AC95-429B-B081-856F86831FFCQ33238942-3DDBE2AE-3D9E-4B98-B04D-5221A78E6304Q33319550-B6656300-78DF-4A0E-94EC-47DB8843F56DQ33349625-9C0654BD-B18B-4AAB-AB1F-FFA66E80463CQ33547675-5CCF29B9-CDB3-4DB3-A07D-773E00B182FBQ33827911-025432C3-E14D-4320-B395-10E3D385780EQ34034198-D733F0B5-1A72-4AE0-982F-346EA36C9697Q34115173-3213289A-7FBF-48D0-807D-CBC0EC39B86CQ34416607-C000750E-EB98-496D-8DE8-064FCA77D341Q34445116-0B804754-0D6F-4C16-9ECF-A428C2D9B996Q34445129-53C22237-5FC3-4F86-B738-BDC94857D518Q34460521-7DEC7C94-062F-4DEC-BCD1-4CE084E24796Q34571481-153AA685-2E8A-450B-9D61-63078BD6416FQ34598124-F9B54C56-A9FC-4D4B-898C-29AA4221D35CQ34764844-C365A6F4-28C0-4375-8123-05E7DBD0CCA8Q35088179-CEA82D1A-E19D-41A9-9C52-8B9E926F4CBBQ35780432-17B5ACE3-EEC9-4E98-85C1-A685D6EDB738Q36920509-53353F1E-8ADD-4676-A25A-9C51A94D86C2Q36930892-38DDB30A-2450-455A-97DB-FC24685243DEQ37154268-5F7A1CF8-5476-48FD-9EFD-B1AF43998B88Q37192199-68545C69-C51D-4821-8584-4EB3CAFC4482Q37201333-BAA472C4-588E-4CA3-B2E7-F02CD07A8227Q37201814-8097F290-EBE8-4590-98D3-860317A07BDDQ37264882-F0DDAD0E-991F-4357-815A-F92C382DDE8CQ37322100-085EF90B-2B4A-4771-8899-C0B30E2C4FA2Q37359049-6FA6488B-3018-40B0-998E-242F2A4015DCQ37389094-6F32E29F-8C51-4060-A8ED-B824DBAEDD24Q38344943-3883373D-1283-4AE5-A155-88F5854070F1Q38969857-1A9D4EF0-EDEC-45C4-8D2A-97E92C5B1830Q40361240-CD817E07-D126-4A1C-A973-7C3F43E03DFC
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Janna Saarela
@ast
Janna Saarela
@en
Janna Saarela
@es
Janna Saarela
@nl
Janna Saarela
@sl
type
label
Janna Saarela
@ast
Janna Saarela
@en
Janna Saarela
@es
Janna Saarela
@nl
Janna Saarela
@sl
prefLabel
Janna Saarela
@ast
Janna Saarela
@en
Janna Saarela
@es
Janna Saarela
@nl
Janna Saarela
@sl
P106
P21
P31
P496
0000-0002-0853-6219